Oncology Drug Approval - Accelerated

Bridging the gap between biomarkers and In Vitro Companion Diagnostics

Board of Directors

Sheridan Snyder, LLB (Hon) - Chairman

Chad Galderisi, D.O. - Vice President of Medical Affairs, MolecularMD

Frederick “Fritz” Eibel, Senior Vice President of Business Development, Wren Laboratories

Matt Rice, MBA - Principal, Ballast Point Ventures

Peter Maag, Ph.D. - President and Chief Executive Officer, XDx, Inc.

Dan Snyder, MBA - President and Chief Executive Officer, MolecularMD

Watch the short video below to learn more about how MolecularMD develops and commercializes specialty molecular diagnostics for oncology applications.